PRIM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.078600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.697400E-01
Normal-vs-Stage2
2.997000E-01
Normal-vs-Stage3
1.446970E-01
Normal-vs-Stage4
3.989600E-01
Stage1-vs-Stage2
7.797400E-01
Stage1-vs-Stage3
1.377030E-01
Stage1-vs-Stage4
8.252000E-01
Stage2-vs-Stage3
3.344200E-01
Stage2-vs-Stage4
9.463600E-01
Stage3-vs-Stage4
2.682400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.785600E-01
Normal-vs-AfricanAmerican
1.229010E-01
Normal-vs-Asian
1.385820E-02
Caucasian-vs-AfricanAmerican
3.849800E-01
Caucasian-vs-Asian
1.397460E-03
AfricanAmerican-vs-Asian
3.002400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.790200E-01
Normal-vs-Female
3.618000E-01
Male-vs-Female
7.580000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.157600E-01
Normal-vs-Age(41-60Yrs)
5.460000E-01
Normal-vs-Age(61-80Yrs)
2.147400E-01
Normal-vs-Age(81-100Yrs)
3.715600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.305800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.269400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.893200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.095570E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.818400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.642600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.134190E-01
Normal-vs-Daily Drinker
1.444170E-01
Normal-vs-Weekly Drinker
2.791000E-01
Normal-vs-Occasional Drinker
9.628400E-01
Normal-vs-Social Drinker
4.283600E-01
Non Drinker-vs-Daily Drinker
9.868000E-01
Non Drinker-vs-Weekly Drinker
8.719600E-01
Non Drinker-vs-Occasional Drinker
1.045890E-02
Non Drinker-vs-Social Drinker
2.639200E-01
Daily Drinker-vs-Weekly Drinker
8.933800E-01
Daily Drinker-vs-Occasional Drinker
2.197700E-02
Daily Drinker-vs-Social Drinker
3.161000E-01
Weekly Drinker-vs-Occasional Drinker
8.344300E-02
Weekly Drinker-vs-Social Drinker
4.943200E-01
Occasional Drinker-vs-Social Drinker
2.328200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.619200E-01
Normal-vs-Grade 2
7.477400E-01
Normal-vs-Grade 3
8.684600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.885600E-01
Grade 1-vs-Grade 3
1.283040E-01
Grade 1-vs-Grade 4
7.619200E-01
Grade 2-vs-Grade 3
1.807560E-02
Grade 2-vs-Grade 4
7.477400E-01
Grade 3-vs-Grade 4
8.684600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.617590E-01
Normal-vs-NonDiabetic
2.917200E-01
Diabetic-vs-NonDiabetic
6.682400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.725000E-01
Normal-vs-NoPancreatitis
3.143200E-01
Pancreatitis-vs-NoPancreatitis
3.218100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.240600E-01
Normal-vs-N1
2.825400E-01
N0-vs-N1
4.069000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.279000E-01
Normal-vs-TP53-NonMutant
6.120600E-01
TP53-Mutant-vs-TP53-NonMutant
3.670600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
